A detailed history of Principal Securities, Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 488 shares of CTLT stock, worth $29,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares
488
Previous 562 13.17%
Holding current value
$29,567
Previous $31.7 Million 13.51%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$53.58 - $57.02 $3,964 - $4,219
-74 Reduced 13.17%
488 $27.4 Million
Q1 2024

May 10, 2024

SELL
$42.56 - $59.82 $28,855 - $40,557
-678 Reduced 54.68%
562 $31.7 Million
Q4 2023

Feb 07, 2024

BUY
$32.18 - $46.57 $39,903 - $57,746
1,240 New
1,240 $55.7 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.